Spike antibody levels and risk of SARS-CoV-2 reinfection: a two-year cohort study in previously infected adults. Wiwe EF, Jorgensen M, Brandt L, Talouzi N, et al. Vaccine 2026;74:128194.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wiwe EF, Jorgensen M, Brandt L, Talouzi N, et al. Spike antibody levels and risk of SARS-CoV-2 reinfection: a two-year cohort study in previously infected adults. Vaccine 2026;74:128194.
PMID: 41500031